comparemela.com
  1. Home
  2. Live Updates
  3. Smo Targeted Anticancer Therapies Congress - Breaking News

Latest Breaking News On - Smo targeted anticancer therapies congress - Page 1 : comparemela.com

TNO155 Plus Spartalizumab or Ribociclib Elicits Disease Control, Is Safe in Advanced Solid Tumors

TNO155 plus spartalizumab or ribociclib was well tolerated and demonstrated disease control in patients with advanced solid tumors.

Israel generalComunidad autonoma de catalunaOmar saavedraAnticancer therapies congressHebron institute of oncologyEarly drug development unitAnticancer therapiesHebron instituteSmo targeted anticancer therapies congressSolid tumors

Targeted Delivery of IL-12 Shows Preliminary Antitumor Activity in Advanced Solid Tumors

A high proportion of patients with metastatic solid tumors experienced stable disease following treatment with the immunocytokine in the DODEKA trial.

Giuseppe curiglianoUniversity of milanoAnticancer therapies congressAnticancer therapiesMedical oncologyClinical divisionEarly drug developmentEuropean instituteIstituto europeoExact sciencesSmo targeted anticancer therapies congressSolid tumors

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.